John Newman
Stock Analyst at Canaccord Genuity
(0)
# 4407
Out of 5,243 analysts
113
Total ratings
39.66%
Success rate
-11.86%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Regeneron Pharmaceut... | Initiates Coverage On: Hold | 165 | 701.38 | -76.47% | 15 | Dec 17, 2024 | |
BioNTech | Maintains: Buy | 171 171 | 114.02 | 49.97% | 7 | Nov 18, 2024 | |
Seres Therapeutics | Maintains: Buy | 10 10 | 0.78 | 1182.05% | 9 | Nov 14, 2024 | |
Atara Biotherapeutic... | Maintains: Strong Buy | 13 21 | 12.1 | 73.55% | 3 | Nov 13, 2024 | |
Ocuphire Pharma | Maintains: Buy | 18 10 | n/a | n/a | 3 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 21 | 12.43 | 68.95% | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 85 115 | 64.59 | 78.05% | 8 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 8 | 0.9 | 788.89% | 6 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 14 | 1.88 | 644.68% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 67 67 | 39.19 | 70.96% | 2 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 38 43 | 18.1 | 137.57% | 1 | Jul 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 6 | 0.21 | 2757.14% | 1 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 11 | 2.44 | 350.82% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 23 25 | n/a | n/a | 5 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | 0.77 | 549.35% | 2 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 9 | n/a | n/a | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 40 72 | n/a | n/a | 4 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 52 44 | 33.22 | 32.45% | 8 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1720 400 | 8.14 | 4814% | 3 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 100 140 | n/a | n/a | 1 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 65 56 | n/a | n/a | 7 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 380 100 | 2.11 | 4639.34% | 2 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Oct 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 210 220 | 7.36 | 2889.13% | 3 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 54 0 | n/a | n/a | 3 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 300 | n/a | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 38 | 13.85 | 174.37% | 2 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 30 | n/a | n/a | 2 | Sep 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 27 | 4.83 | 459.01% | 2 | Sep 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Speculative Buy | n/a | n/a | n/a | 1 | Sep 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 18 | n/a | n/a | 1 | Aug 30, 2016 |